Response by treatment regimens used for induction
| Induction regimens . | Overall, n = 1179 . | Primary refractory, n = 285 . | Achieved CR, n = 894 . | P . |
|---|---|---|---|---|
| HiDAc + anthracyclines | 765 | 181 (64) | 584 (65) | .58 |
| HiDAc + none anthracycline chemotherapy | 414 | 104 (36) | 310 (35) |
| Induction regimens . | Overall, n = 1179 . | Primary refractory, n = 285 . | Achieved CR, n = 894 . | P . |
|---|---|---|---|---|
| HiDAc + anthracyclines | 765 | 181 (64) | 584 (65) | .58 |
| HiDAc + none anthracycline chemotherapy | 414 | 104 (36) | 310 (35) |
HiDAC indicates high-dose ara-C; and CR, complete response.